Treatments for medullary carcinoma
The following are treatment options for medullary carcinoma of the thyroid. Your healthcare team will suggest treatments based on your needs and the stage of the cancer. They will work with you to develop a treatment plan.
Surgery is the first treatment for most medullary carcinomas. Surgery is often done after testing, and sometimes as treatment, for other tumours that develop when medullary carcinoma is associated with multiple endocrine neoplasia type 2 (MEN2), such as
Total thyroidectomy completely removes the thyroid. It is usually the first type of surgery done.
Neck dissection removes lymph nodes from the neck. The surgeon may also remove other tissues around the thyroid. The type of neck dissection done depends on the size of the tumour and if the doctor thinks there is cancer in the lymph nodes in the neck based on the results of an ultrasound. It is often done at the same time as the total thyroidectomy.
Surgery for metastasis could be used to treat medullary carcinoma that has spread to other organs and is causing symptoms. Find out more about metastatic cancer.
Palliative surgery may be done to
Hormonal therapy @(Model.HeadingTag)>
Hormonal therapy is a standard treatment after surgery for medullary carcinoma. It is used to replace the hormone thyroxine, which would normally be made by the thyroid.
The type of hormonal therapy used is levothyroxine (Synthroid, Eltroxin). It is given as a pill once a day. You will have to take levothyroxine for the rest of your life if you have a total thyroidectomy.
Radiation therapy @(Model.HeadingTag)>
External beam radiation therapy may be offered for medullary carcinoma. It may be used to treat cancer in the neck that can’t be removed with surgery. It may also be used to treat cancer that comes back, or recurs, in the neck.
If medullary carcinoma spreads to the bone, external beam radiation therapy is sometimes used as a palliative treatment to relieve symptoms such as pain. Find out more about bone metastases.
Targeted therapy @(Model.HeadingTag)>
You may be offered targeted therapy for locally advanced or metastatic medullary carcinoma. It may also be used to treat recurrent medullary carcinoma that can’t be removed with surgery (it is unresectable) and the cancer continues to grow and spread (it is progressing). Vandetanib (Caprelsa) is a targeted therapy drug used for medullary carcinoma. It is given as a pill.
You may be offered chemotherapy for locally advanced or metastatic medullary carcinoma if targeted therapy doesn’t work. It is usually given as a palliative treatment to help relieve symptoms. Chemotherapy drugs used for medullary carcinoma include doxorubicin (Adriamycin) and dacarbazine (DTIC).
Alberta Health Services. Targeted therapy for Locally Advanced Unresectable or Metastatic Medullary Thyroid Carcinoma: Clinical Practice Guideline ENDO-002 Version 1. 2012: http://www.albertahealthservices.ca/hp/if-hp-cancer-guide-endo002-targeted-therapy-mtc.pdf.
American Society of Clinical Oncology. Thyroid Cancer. 2015: http://www.cancer.net/cancer-types/thyroid-cancer/view-all.
Davidge-Pitts CJ, Thompson GB . Thyroid tumors. DeVita VT Jr, Lawrence TS, Rosenberg SA. Cancer: Principles and Practice of Oncology. 10th ed. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2015: 82:1175-1188.
Davidson BJ, Newkirk KA, Burman KD . Cancer of the thyroid and the parathyroid: general principles and management. Harrison LB, Sessions RB, Kies MS (eds.). Head and Neck Cancer: A Multidisciplinary Approach. 4th ed. Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins; 2014: 28A:779-824.
Jonklaas J, Bianco AC, Bauer AJ, et al . Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement. Thyroid. 2014: http://online.liebertpub.com/doi/abs/10.1089/thy.2014.0028.
Lentsch EJ. Medscape Reference: Thyroid Cancer Treatment Protocols. 2015: http://emedicine.medscape.com/article/2007769-overview.
National Cancer Institute. Thyroid Cancer Treatment for Health Professionals (PDQ®). 2015: http://www.cancer.gov/types/thyroid/hp/thyroid-treatment-pdq.
National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Thyroid Carcinoma (Version 2.2015). http://www.nccn.org/professionals/physician_gls/f_guidelines.asp.
Sawka AM, Brierley JD, Ezzat S, Goldstein DP . Managing newly diagnosed thyroid cancer. CMAJ. 2014: http://www.cmaj.ca/content/186/4/269.full.